Problems › Our Sales Cycle Is Too Long › Accounting & Advisory Firms
Long cycles here usually trace to the managing partner failing to build an internal case for reallocating chargeable hours from compliance to advisory, rather than any shortfall in client persuasion. The version of this question that applies to accounting firms is not the generic one. Compliance fee compression and inability to shift hours to advisory without reducing statutory output — so an answer that ignores 82% realisation rate will be confidently wrong. The analysis has to start from 71% billable utilisation and 34% advisory win rate rather than from revenue.
Long cycles here usually trace to the managing partner failing to build an internal case for reallocating chargeable hours from compliance to advisory, rather than any shortfall in client persuasion. The version of this question that applies to accounting firms is not the generic one. Compliance fee compression and inability to shift hours to advisory without reducing statutory output — so an answer that ignores 82% realisation rate will be confidently wrong. The analysis has to start from 71% billable utilisation and 34% advisory win rate rather than from revenue.
A cycle that runs long rarely stalls on client interest in advisory work. It stalls at the point where the firm must justify diverting time from statutory engagements that protect the 82% realisation rate and 71% billable utilisation, because any reduction in compliance output directly hits gross margin and work-in-progress recovery.
Shortening the cycle therefore centres on equipping the internal advocate with the figures needed to win the internal argument: the projected lift in advisory revenue against the risk of lower compliance output, the answer on utilisation drag, and the comparison of retaining 91% compliance clients versus attempting to grow the 34% advisory win rate.
The second common cause is attempting to sell advisory services to a compliance client who lacks authority over spend decisions inside their own organisation, which simply adds an extra approval loop that never appears in the firm's pipeline until after the original forecast date.
These three together are the signature. One on its own usually points somewhere else.
✓ Advisory opportunities sit for multiple quarters while chargeable hours remain locked in compliance work with no visible shift in the WIP schedule.
✓ Repeated forecast slippage on advisory lines while overall realisation rate and utilisation figures show no improvement quarter on quarter.
✓ Lost advisory pursuits where the client record shows continued compliance work only and no new service lines opened.
The move that usually makes it worse. Increasing follow-up calls and emails, which adds pressure on the partner without supplying new internal justification material on realisation, utilisation or gross margin impact.
It is for you if you run or finance an accounting firm and deals consistently stall at the same stage. It is the situation where the numbers are available but nobody has put them in an order that produces a decision.
It is not for you if Percision is the wrong tool if you already know the answer and only need execution capacity, or if the business is pre-revenue — then the constraint is evidence about the market, not analysis of your own figures. Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library. Also wrong if you need facilitation, politics, or someone to sit with a lender or buyer. Those are human jobs.
Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library.
Below is an excerpt from a real run of this analysis on an accounting firm. It is a sample profile rather than a customer, and it is unedited engine output — this is the format you get, on your own numbers.
The subject is Pennmark Advisory, a sample company profile used for testing rather than a customer — 43.2m total revenue with 210 fte staff.
Excerpt from a real Percision run · Quick Market Scan · sample company profile
The move. Convert 15,000 compliance hours into $1.9M incremental EBITDA by embedding advisory inside existing client relationships.
| Investment required | $0.8M-$1.2M for 6 FTE conversion specialists (salary + training); funded entirely from existing $7.8M EBITDA within 24-month payback constraint |
| Expected return | Base case: $1.9M incremental EBITDA on $1.0M investment = 1.9× return within 24 months; Low case: $1.4M EBITDA (26% lower pipeline conversion); High case: $2.4M EBITDA (26% higher win rate) |
| Revenue, year 1 | $0.6M incremental advisory revenue (partial year, 6 specialists hired Q2 2027) |
| Revenue, year 2 | $1.9M incremental EBITDA (full-year run rate) |
| Revenue, year 3 | $2.8M incremental EBITDA (additional 4 specialists funded by Year 2 cash flow) |
| Exit criteria | Strategy should be reversed if, within 18 months, (a) advisory win rate falls below 25% for two consecutive quarters, OR (b) compliance retention drops below 88%, OR (c) incremental EBITDA from conversion specialists fails to reach $800K annual run-rate by Month 18 |
This is one move out of a full analysis. Read a complete report — every page, no email required.
This question routes to Go-to-Market & Commercial Strategy, one of 29 engagements the platform runs. For accounting firms it works through 82% realisation rate, 71% billable utilisation, 34% advisory win rate and 91% compliance client retention, then produces the sequence rather than a list of options — which move first, what it funds, and the observation that would say the sequence is wrong.
You watch the analysis get built before paying anything. Read a complete report here if you would rather see the depth first.
Find the stage where deals sit longest and work out what the buyer has to do there. It is almost always an internal approval, and the fix is material rather than persuasion.
It compresses the last step and does nothing to the stalls earlier in the cycle, which is where the time actually goes. It also teaches buyers that waiting is rewarded.
No, if the deal size and win rate justify it. It becomes a problem when the cycle is longer than your cash conversion allows, which is a financing constraint rather than a sales one.
Materially, yes. Compliance fee compression and inability to shift hours to advisory without reducing statutory output — which changes both the diagnosis and the order of the fixes. The metrics that decide it here are 82% realisation rate, 71% billable utilisation, 34% advisory win rate, and an answer built on industry-general benchmarks will usually point at the wrong one first.
Less than most people expect. Your last twelve months of revenue and cost split the way you already split it, plus whatever you hold on 82% realisation rate and 71% billable utilisation. The analysis is explicit about what it is assuming where your data stops, which is more useful than waiting for numbers you may never have.
Percision is the wrong tool if you already know the answer and only need execution capacity, or if the business is pre-revenue — then the constraint is evidence about the market, not analysis of your own figures. Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library. Also wrong if you need facilitation, politics, or someone to sit with a lender or buyer. Those are human jobs.
Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library.
Describe the situation in your own words and we will tell you which analysis answers it — before you sign up for anything.
Describe my situation →Prefer to skip ahead? Go straight to the free diagnostic.
English · Español · Deutsch · Português · Français · Italiano · Nederlands · 日本語 · 한국어 · 中文 · Polski · Svenska · Türkçe · العربية · Tiếng Việt · ไทย · हिन्दी · עברית